These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. How do the epidemiology of paediatric methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus bacteraemia differ? Abernethy J; Sharland M; Johnson AP; Hope R J Med Microbiol; 2017 Jun; 66(6):737-743. PubMed ID: 28598316 [TBL] [Abstract][Full Text] [Related]
25. Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia. Abraham J; Mansour C; Veledar E; Khan B; Lerakis S Am Heart J; 2004 Mar; 147(3):536-9. PubMed ID: 14999206 [TBL] [Abstract][Full Text] [Related]
26. Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study. Wang JT; Hsu LY; Lauderdale TL; Fan WC; Wang FD PLoS One; 2015; 10(12):e0144710. PubMed ID: 26690351 [TBL] [Abstract][Full Text] [Related]
27. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Yaw LK; Robinson JO; Ho KM Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461 [TBL] [Abstract][Full Text] [Related]
28. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Melzer M; Eykyn SJ; Gransden WR; Chinn S Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667 [TBL] [Abstract][Full Text] [Related]
29. Staphylococcal bacteraemia: the hospital or the home? A review of Staphylococcus aureus bacteraemia at Concord Hospital in 1993. O'Kane GM; Gottlieb T; Bradbury R Aust N Z J Med; 1998 Feb; 28(1):23-7. PubMed ID: 9544382 [TBL] [Abstract][Full Text] [Related]
30. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017. Coombs GW; Daley DA; Lee YT; Pang S Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665 [TBL] [Abstract][Full Text] [Related]
31. Predictors of septic shock in patients with methicillin-resistant Staphylococcus aureus bacteremia. Lam SW; Bauer SR; Neuner EA Int J Infect Dis; 2012 Jun; 16(6):e453-6. PubMed ID: 22497963 [TBL] [Abstract][Full Text] [Related]
32. Comparison of outcome and clinical characteristics of bacteremia caused by methicillin-resistant, penicillin-resistant and penicillin-susceptible Staphylococcus aureus strains. Jokinen E; Laine J; Huttunen R; Rahikka P; Huhtala H; Vuento R; Vuopio J; Syrjänen J Infect Dis (Lond); 2017 Jul; 49(7):493-500. PubMed ID: 28276799 [TBL] [Abstract][Full Text] [Related]
33. Predictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study. Ok HS; Lee HS; Park MJ; Kim KH; Kim BK; Wi YM; Kim JM Korean J Intern Med; 2013 Nov; 28(6):678-86. PubMed ID: 24307843 [TBL] [Abstract][Full Text] [Related]
34. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection? Ben-David D; Novikov I; Mermel LA Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266 [TBL] [Abstract][Full Text] [Related]
35. Long-term methicillin-resistant Staphylococcus aureus bacteremia persisting for more than 2 weeks: risk factors and outcomes. Lee YM; Chong YP; Kim M; Eom Y; Kim ES; Kim M; Park KH; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):773-781. PubMed ID: 31873861 [TBL] [Abstract][Full Text] [Related]
36. Epidemiology and hospital readmission associated with complications of Staphylococcus aureus bacteremia in pediatrics over a 25-year period. Le J; Dam Q; Tran T; Nguyen A; Adler-Shohet FC; Kim S; Schmidt K; Lieberman JM; Bradley JS Epidemiol Infect; 2017 Sep; 145(12):2631-2639. PubMed ID: 28748772 [TBL] [Abstract][Full Text] [Related]
37. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus. Falcón R; Mateo E; Oltra R; Giménez E; Albert E; Torres I; Navarro D Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):903-912. PubMed ID: 30729396 [TBL] [Abstract][Full Text] [Related]
38. Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia. Wang FD; Chen YY; Chen TL; Liu CY Am J Infect Control; 2008 Mar; 36(2):118-22. PubMed ID: 18313513 [TBL] [Abstract][Full Text] [Related]